2-Methyl-thiazolidine-2,4-dicarboxylic acid protects against paracetamol induced toxicity in human liver derived HepG2 cells.

@article{Wodek19972Methylthiazolidine24dicarboxylicAP,
  title={2-Methyl-thiazolidine-2,4-dicarboxylic acid protects against paracetamol induced toxicity in human liver derived HepG2 cells.},
  author={Lidia B Włodek and Hans Rommelspacher},
  journal={Acta biochimica Polonica},
  year={1997},
  volume={44 4},
  pages={
          759-66
        }
}
The effects of 2-methyl-thiazolidine-2,4-dicarboxylic acid (CP) on paracetamol-induced toxicity were investigated and evaluated in a human liver derived HepG2 cell line. Incubation of the cells with CP (2 mM and 10 mM) drastically attenuated the GSH and cysteine depletion caused by toxic concentrations of paracetamol (1 mM and 5 mM). When CP (10 mM) was introduced alone into the medium, the level of malondialdehyde and the reactive oxygen species were maintained at the control levels with a… 

Antioxidant effect of thiazolidine molecules in cell culture media improves stability and performance

The results confirm that cells in vitro are not cultured in an oxidant‐free environment and indicate that thiazolidines are an interesting class of antioxidant molecules, capable of increasing cell culture media stability and process performance.

[The different aspects of the biological role of glutathione].

There is currently an intensive search for possibilities of modulating cellular glutathione and cysteine levels, and this problem can be the subject of interdisciplinary studies combining such scientific fields as biology, pharmacology, toxicology, and clinical medicine.

Acetaminophen-Induced Hepatotoxicity: Still an Impor- tant Issue

In Japan, APAP has usually been consumed as combination tablets or granules and rarely used alone except as a suppository, and since recent reports that the use of salicylic acid in combination cold remedies is associated with Acetaminophen-Induced Hepatotoxicity, it is still an Important Issue.

Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges

This review summarized the strategies of crossing BBB, properties of EAAT3 and its natural substrates, Cys and its donors, and Cys donor-based brain-targeting prodrugs by referring to recent investigations and the challenges that are faced with and future research orientations were addressed.

Sulfane sulfur - new findings on an old topic.

New findings in the field of sulfane sulfur's biological role, and disruption of its level in some patho/physiological conditions are focused on.

References

SHOWING 1-10 OF 27 REFERENCES

2‐Methyl‐thiazolidine‐2,4‐dicarboxylic acid as prodrug of L‐cysteine. Protection against paracetamol hepatotoxicity in mice

It is demonstrated that the cysteine prodrug CP is effective in preventing liver damage of a hepatotoxic dose of paracetamol in vivo, and has the long duration of the effect of more than 12 h.

[Growth-promoting action of L-cysteine and its related compounds on Ehrlich ascites tumor cells in vitro].

The findings suggest that L-CYS added to BM is changed in a non-SH compound (possibly L-cystine) that is taken up into the cells and increases the intracellular free SH, resulting in the cell growth promotion.

N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen.

Results of partitioning experiments indicate that N-acetyl-p-benzoquinone imine is a major metabolite of acetaminophen, a considerable fraction of which is rapidly reduced back toacetaminophen.

Ethanol-induced changes in the content of thiol compounds and of lipid peroxidation in livers and brains from mice: protection by thiazolidine derivatives.

A new treatment for the tissue-damaging effects of chronic ethanol ingestion is demonstrated and the concentration of total glutathione was increased in the brain suggesting protective mechanisms in this organ and possibly a supply from other organs.

Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.

It is demonstrated that selective differential chemotherapy responses of normal versus tumor cells is possible by manipulating the GSH synthetic cycle and that manipulation in GSH levels might yield a therapeutic gain for carefully selected chemotherapy drugs.